Zentek (NASDAQ:ZTEK) Releases Earnings Results

Key Points

• Zentek (NASDAQ:ZTEK) reported a quarterly earnings per share of ($0.01) with a negative net margin of 1,186.72% and a negative return on equity of 58.87%.
• The company's stock fell 3.8% to $0.81, with trading volume higher than its average at 42,674 shares.
• Zentek focuses on the research and development of graphene and related nanomaterials, producing products such as antimicrobial coatings and surgical masks.

Zentek (NASDAQ:ZTEK - Get Free Report) issued its earnings results on Thursday. The company reported ($0.01) earnings per share (EPS) for the quarter, Zacks reports. The company had revenue of $0.04 million during the quarter. Zentek had a negative return on equity of 53.31% and a negative net margin of 981.17%.

Zentek Trading Up 0.1%

Shares of NASDAQ:ZTEK traded up $0.00 during midday trading on Tuesday, reaching $0.74. 8,327 shares of the company's stock were exchanged, compared to its average volume of 44,743. The firm's 50 day simple moving average is $1.06 and its two-hundred day simple moving average is $1.17. The company has a debt-to-equity ratio of 0.01, a current ratio of 1.25 and a quick ratio of 1.00. The stock has a market cap of $77.28 million, a price-to-earnings ratio of -15.10 and a beta of 0.47. Zentek has a fifty-two week low of $0.50 and a fifty-two week high of $1.84.

Zentek Company Profile

Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds.